Page last updated: 2024-10-29

avapro and Cholecystitis

avapro has been researched along with Cholecystitis in 1 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Cholecystitis: Inflammation of the GALLBLADDER; generally caused by impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, or other diseases.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Foruny Olcina, JR1
Moreira Vicente, VF1
Gómez García, M1
Morell Hita, JL1

Other Studies

1 other study available for avapro and Cholecystitis

ArticleYear
[Irbesartan-induced acute hepatitis].
    Gastroenterologia y hepatologia, 2004, Volume: 27, Issue:2

    Topics: Acute Disease; Antihypertensive Agents; Biphenyl Compounds; Chemical and Drug Induced Liver Injury;

2004